Showing results (31-40 of 260) with videos related to
Sort By:
Pageof 26
Ejhaem|November 29, 2023
Current directions in the treatment of classical Hodgkin lymphomaFrank G Keller, Brad Kahl, Jonathan W FriedbergLancet (London, England)|January 25, 2021
Classical Hodgkin lymphomaPauline Brice, Eric de Kerviler, Jonathan W FriedbergJournal of Cutaneous Pathology|July 26, 2002
Clonal analysis of cutaneous fibrous histiocytoma (dermatofibroma)Pei Hui, Earl J Glusac, John H Sinard, et al.Blood Cells, Molecules & Diseases|February 6, 2014
The role of EVI1 in myeloid malignanciesCarolyn Glass, Michael Wilson, Ruby Gonzalez, et al.Oncology (Williston Park, N.Y.)|April 3, 2007
Novel concepts in radioimmunotherapy for non-Hodgkin's lymphomaJulia Schaefer-Cutillo, Jonathan W Friedberg, Richard I FisherClinical Advances in Hematology & Oncology : H&O|August 18, 2010
Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapyBrad S Kahl, Bruce D Cheson, Jonathan W FriedbergClinical Advances in Hematology & Oncology : H&O|February 25, 2012
Accurate reporting of adverse events in chronic lymphocytic leukemia and non-Hodgkin lymphomaBruce D Cheson, Kanti R Rai, Jonathan W FriedbergBest Practice & Research. Clinical Haematology|June 13, 2012
Novel agents in mantle cell lymphomaMarcus S Noel, Jonathan W Friedberg, Paul M BarrBiochemistry|February 29, 2008
Regulation of the calreticulin gene by GATA6 and Evi-1 transcription factorsYuanyuan Qiu, Jeffrey Lynch, Lei Guo, et al.The Journal of Biological Chemistry|April 30, 2016
EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory ElementsMichael Wilson, Vasiliki Tsakraklides, Minh Tran, et al.Pageof 26